About Us
Press
Risk decisions that looked straightforward six months ago may not look that way today. Grey-area risk is putting more pressure on legal, compliance, trust and safety, and risk teams. In this article in Legal Reader, LegitScript’s Andy Bayley explains how organizations need a way to turn legal interpretation, risk signals, and operational judgment into decisions teams can apply in real time.
For years, the payments industry treated trust as something established once at underwriting and then relied on as the relationship scaled. Now, that approach is breaking down as technology allows bad actors to submit merchant applications at scale. In this article by LegitScript’s Dan Frechtling, learn how payments companies are combatting this problem.
There’s a new acronym roaming the C-suite. The so-called COFO — a hybrid chief operating and financial officer — is more common than ever, marking a structural shift in how companies are deciding who runs the business. In this article in Global Finance, LegitScript’s COFO Jaylene Kunze talks about the role.
LegitScript announced an expanded partnership with Google to certify telemedicine providers in Spain. The policy update allows telemedicine businesses operating in Spain to apply for LegitScript Healthcare Certification and promote their services on Google advertising platforms.
In this episode of the SEAA Podcast, Leo Patching, founder of Kompliant (now part of LegitScript), and Tom Lineen, President of WestTown Payments, explore one of the most important shifts happening in financial services today: the evolution of AI-powered underwriting, merchant risk, and compliance. Listen now.
In a recent Wired feature on the “turnkey telehealth” boom, our CEO Scott Roth talks about what happens when infrastructure providers make it possible for literally anyone — a gym, an influencer, a marketing agency — to open a virtual clinic overnight. Keep reading to learn more about this dynamic space and the potential risks.
LegitScript announced the launch of the Compliance Collective, a curated partner program designed to help LegitScript-certified healthcare businesses address the full spectrum of compliance requirements they face beyond certification. Keep reading to learn what this means for you and your business.
The FDA has not approved retatrutide for human use other than for clinical trials. Even so, injections of the investigational weight loss drug have become a craze among Americans obsessed with fitness and beauty. Learn more about this trending product in a story by Public Citizen.
LegitScript’s new advisory and research solution gives compliance, policy, and trust and safety teams direct access to regulatory, investigative, and risk experts with 20+ years of intelligence across 60+ high-risk verticals. Learn more about this new offering.
What are some of the defining lessons in a leader’s career? In this interview with LegitScript CFO Jaylene Kunze, we learn about the challenges that have shaped her career and hear how she approaches leadership at LegitScript. Listen now.